I joined the Infectious Diseases Epidemiology and Analytics G5 Unit in 2021. With a background in the P. vivax genomic and sero-surveillance, I am now interested in developing quantitative and qualitative serological and genetic tools to better understand the acquired immunity to diverse infectious pathogens.
Click to view graph
Click to view timeline
- Institut Pasteur, Paris, France. PhD fellow. 2017 – 2021.
- Walter and Eliza Hall Institute of Medical Research, Parkville, Australia. 2017, Aug – Sep.
- Institute of Tropical Medicine (ITG), Antwerp, Belgium. 2015, April – June.
- Universidad Peruana Cayetano Heredia, Lima, Peru. 2012 – 2017.
- Université Sorbonne, Paris, France. 2021 PhD in Epidemiology.
- Universidad Peruana Cayetano Heredia, Lima, Peru. 2014. MSc in Biochemistry and Molecular Biology.
- Universidad Nacional Federico Villarreal, Lima, Peru. 2010. BSc in Medical Technology.
2021Investigating differences in village-level heterogeneity of malaria infection and household risk factors in Papua New Guinea., Sci Rep 2021 Aug; 11(1): 16540.
2021Kinetics of the SARS-CoV-2 antibody response and serological estimation of time since infection., J Infect Dis 2021 Jul; (): .
2021PvMSP8 as a Novel Plasmodium vivax Malaria Sero-Marker for the Peruvian Amazon., Pathogens 2021 Mar; 10(3): .
2021Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study., Lancet Microbe 2021 Feb; 2(2): e60-e69.
2021Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts., PLoS Negl Trop Dis 2021 02; 15(2): e0009165.
2019Delimitation of the upstream region of NFKBIA gene associated with HTLV-1-associated myelopathy/tropical spastic paraparesis using candidate Tag-SNPs in Peruvian HTLV-1 infected individuals., Infect Genet Evol 2019 11; 75(): 103929.
2017The FAS-670 AA genotype is associated with high proviral load in peruvian HAM/TSP patients., J Med Virol 2017 04; 89(4): 726-731.